---
title: "Bama Tea drops 7%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306205769.md"
description: "Bama Tea fell 6.52% to HK$21.50. Down 11.69% over five sessions and down 20.29% YTD."
datetime: "2026-11-20T02:22:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306205769.md)
  - [en](https://longbridge.com/en/news/306205769.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306205769.md)
generator: "portal-rs"
---

# Bama Tea drops 7%

Bama Tea (6980.HK) fell nearly **7%** in Hong Kong trading, last at **HK$21.50**.

The stock is down 11.69% over the past five sessions and down 20.29% year to date. It sits 62.68% below its 52-week high of HK$57.61. Volume was 0.27 times its average.

The Hang Seng Index is down 5.23% over the past five sessions and down 12.60% year to date.

The packaged foods and meats industry index fell 1.6% over the same period.

The company entered into a tea product sales and procurement framework agreement with its connected subsidiary Wang Xinji for the period from Jan. 1, 2027 to Dec. 31, 2029. The annual transaction caps are set at 3 million yuan for 2027, 5 million yuan for 2028 and 8 million yuan for 2029.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [06980.HK](https://longbridge.com/en/quote/06980.HK.md)

## Related News & Research

- [Bama Tea Files Next Day Disclosure Return to HKEX Announcing Share Buyback](https://longbridge.com/en/news/305807822.md)
- [Bama Tea expects H1 profit attributable to shareholders to rise at least 60%](https://longbridge.com/en/news/292328431.md)
- [Enterprise Says Partisan Spending Proposals May Complicate Housing Funding Deal](https://longbridge.com/en/news/306339503.md)
- [NRB's (KOSDAQ:475230) Earnings Are Weaker Than They Seem](https://longbridge.com/en/news/306339423.md)
- [INFINITT Healthcare's (KOSDAQ:071200) Shareholders Have More To Worry About Than Lackluster Earnings](https://longbridge.com/en/news/306338723.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**